
New pleuromutilin antibiotic IV and oral tablets.

New pleuromutilin antibiotic IV and oral tablets.

Humira successor indicated for adults with inadequate response or intolerance to methotrexate.

Sexual harassment can come from both coworkers and patients.

First new drug approval for the condition in nearly a decade.

Products marketed as a numbing agent/topical anesthetic used prior to tattoo application.

How can we protect the health of the millions of people who protect our own?


Prepare for the back-to-school rush!


Pharmacogenetic testing, contraceptives, and more!

Medication errors cost the U.S. healthcare system $21 billion annually.

CarePass program appeals to wide consumer audience, trial finds.

"The real problem to be solved is “Why do patients struggle to buy their prescriptions?” writes Frisch.

2019 cases greater than five-year trend.

More jobs in jeopardy as chains struggle to save expenses.

Kinase inhibitor oral capsules.

PBMs are making it nearly impossible to navigate the waters of healthcare, writes Kreckle.

Dispensing robots began rolling out to retail and ambulatory care pharmacies in the 1990s.


Independent pharmacies differentiate with service and high-touch care.

Companies have been promoting unsubstantiated health and treatment claims.

New program to fund community pharmacy reinvention efforts.

TNF blocker biosimilar to Humira (adalimumab, Abbvie).

Prosecutors are bringing accountability to the opioid epidemic.

Q&A from ThoughtSpot 2019.